Jiangsu Hengrui Medicine
600276.SS
₹656.38
Share price
1.42%
Change (1 day)
33.19%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Total assets
Total assets on the balance sheet as of March 2025 : ₹604.47 Billion
According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are ₹604.47 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | ₹515.66 B | 1.43% |
| 2022-12-31 | ₹508.37 B | 10.84% |
| 2021-12-31 | ₹458.66 B | 17.78% |
| 2020-12-31 | ₹389.42 B | 38.44% |
| 2019-12-31 | ₹281.30 B | 22.9% |
| 2018-12-31 | ₹228.88 B | 29.28% |
| 2017-12-31 | ₹177.04 B | 26.25% |
| 2016-12-31 | ₹140.23 B | 18.97% |
| 2015-12-31 | ₹117.88 B | 26.74% |
| 2014-12-31 | ₹93.00 B | 26.18% |
| 2013-12-31 | ₹73.70 B | 42.44% |
| 2012-12-31 | ₹51.74 B | 27.6% |
| 2011-12-31 | ₹40.55 B | 53.61% |
| 2010-12-31 | ₹26.39 B | 29.59% |
| 2009-12-31 | ₹20.37 B | 28.09% |
| 2008-12-31 | ₹15.90 B | 43.64% |
| 2007-12-31 | ₹11.07 B | 32.89% |
| 2006-12-31 | ₹8.33 B | 16.23% |
| 2005-12-31 | ₹7.16 B | 8.99% |
| 2004-12-31 | ₹6.57 B | -17.68% |
| 2003-12-31 | ₹7.98 B | 14.48% |
| 2002-12-31 | ₹6.97 B | 6.98% |
| 2001-12-31 | ₹6.52 B |